Related Experiment Videos
Angiotensin-converting enzyme inhibitors post-myocardial infarction
1Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA.
Cardiology Clinics
|August 1, 1995
Summary
Angiotensin-converting enzyme (ACE) inhibitors significantly reduce heart attack morbidity and mortality, especially in patients with reduced heart function. Early or later use post-myocardial infarction improves survival and prevents ischemic events.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Multiple large-scale clinical trials (SOLVD, SAVE, AIRE, GISSI-III, ISIS-IV, Chinese Captopril Trial) evaluated ACE inhibitors.
- Ischemic heart disease and myocardial infarction (MI) remain leading causes of morbidity and mortality.
- Ventricular dysfunction is a critical factor in post-MI outcomes.
Purpose of the Study:
- To synthesize findings from major clinical trials on ACE inhibitor efficacy in cardiovascular disease.
- To establish the role of ACE inhibitors in reducing morbidity and mortality post-myocardial infarction.
- To provide recommendations for ACE inhibitor use in patients with varying ventricular function.
Main Methods:
- Meta-analysis and synthesis of results from randomized controlled trials.
- Focus on ACE inhibitors including enalapril, captopril, ramipril, and lisinopril.
- Analysis of patient subgroups based on ventricular function and timing of MI.
Main Results:
- ACE inhibitors significantly reduce morbidity and mortality in patients with ischemic heart disease and myocardial infarction.
- Improved survival and reduced ischemic events observed in patients with depressed systolic function (SOLVD, SAVE).
- Early post-MI initiation shows small but significant benefits (GISSI-III, ISIS-IV), while delayed initiation also provides benefits (SOLVD).
Conclusions:
- ACE inhibitors are crucial for preventing ischemic events in post-MI patients, particularly those with reduced ejection fraction.
- All patients with depressed systolic function, symptomatic or not, should trial an ACE inhibitor.
- ACE inhibitors should be initiated post-MI (after 24 hours if acute) alongside other standard therapies, even in patients with normal systolic function if anterior MI is present.